Improving the Adherence of Type 2 Diabetes Mellitus Sufferers with Pharmacy Care: A Scientific Assessment of Randomized Managed Trials

Authors: Saad Ali Al Arfaj, Mohammed Khalid Al Rabiah, Ismail Haider Baqtayyan

DOI: https://doi.org/10.37082/IJIRMPS.v3.i4.1696

Short DOI: https://doi.org/gs8fb6

Country: Dubai

Full-text Research PDF File:   View   |   Download

Abstract: Background: Medication adherence (MA) is associated with better disease control (glycated haemoglobin, blood pressure, and lipid profile), lower rates of death and diabetes-related complications, higher quality of life, and lower health-care resource utilisation in adults with type 2 diabetes mellitus (T2D).

Methods:Patients with Type 2 diabetes who came to clinics for routine care were asked about pharmacy care to capture comorbidity (hypertension and hyperlipidemia/dyslipidemia), diabetes-related complications, duration of diabetes, HbA1c, blood pressure, lipids, number and types of medications used.

Results: There is, however, a scarcity of research on the impact of diabetes-related distress, depression, and health-related quality of life on MA.

Conclusion: The World Health Organization emphasises that the impact of interventions aimed at improving adherence has far-reaching consequences than specific medical interventions.

Keywords: Medication Adherence, Type-2 Diabetes Mellitus, Managed Trials of Type-2 diabetes, Improve Adherence of Type-2 diabetes

Paper Id: 1696

Published On: 2015-08-11

Published In: Volume 3, Issue 4, July-August 2015

Cite This: Improving the Adherence of Type 2 Diabetes Mellitus Sufferers with Pharmacy Care: A Scientific Assessment of Randomized Managed Trials - Saad Ali Al Arfaj, Mohammed Khalid Al Rabiah, Ismail Haider Baqtayyan - IJIRMPS Volume 3, Issue 4, July-August 2015. DOI 10.37082/IJIRMPS.v3.i4.1696

Share this